Clincosm LogoSign in Get a demo

Carcinoma, Non-Small-Cell Lung

Showing NaN - NaN of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in New York, Philadelphia (Pembrolizumab, Carboplatin, Nab-paclitaxel)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • New York, New York
  • +2 more
Dec 10, 2019

NSCLC, NSCLC Trial in Spain, United States (CC-223, erlotinib, CC-223, oral azacitidine)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Non-Small Cell Lung Cancer
  • CC-223, erlotinib
  • CC-223, oral azacitidine
  • Los Angeles, California
  • +8 more
Nov 7, 2019

NSCLC Trial in Worldwide (Emibetuzumab, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +58 more
Sep 6, 2019

NSCLC, NSCLC, NSCLC Trial in United States (Erlotinib (tarceva), Placebo)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Erlotinib (tarceva)
  • Placebo
  • Birmingham, Alabama
  • +64 more
Sep 4, 2019

Carcinoma, Non-small-cell Lung Trial in Lebanon, New York (erlotinib and bexarotene)

Completed
Has Results
  • Carcinoma, Non-small-cell Lung
  • erlotinib and bexarotene
  • Lebanon, New Hampshire
  • +1 more
Dec 14, 2018

Lung Cancer, Small Cell Lung Cancer, NSCLC Trial in Worldwide (Ipilimumab, Placebo, Paclitaxel)

Completed
Has Results
  • Lung Cancer
  • +2 more
  • Birmingham, Alabama
  • +71 more
Jun 18, 2018

NSCLC, Lung Tumors Trial in Worldwide (HKI-272)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Los Angeles, California
  • +18 more
Apr 6, 2018

NSCLC Trial in Worldwide (PF-02341066)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +278 more
Nov 17, 2016

NSCLC Trial in Worldwide (PF-02341066, Pemetrexed, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Little Rock, Arkansas
  • +263 more
Oct 31, 2016

NSCLC Trial in United States (afatinib)

Approved for marketing
  • Carcinoma, Non-Small-Cell Lung
  • Mobile, Alabama
  • +65 more
Nov 29, 2016

NSCLC Trial in United States (Paclitaxel and carboplatin)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Paclitaxel and carboplatin
  • Hot Springs, Arkansas
  • +55 more
Sep 16, 2016

NSCLC Trial in Taiwan, United States (BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • BIBW 2992
  • Bakersfield, California
  • +29 more
Jul 28, 2016

NSCLC Trial in Worldwide (ZD6474, Placebo, ZD1839)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Pine Bluff, Arkansas
  • +45 more
Aug 22, 2016

NSCLC Trial in Worldwide (MM-121, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +37 more
Jul 12, 2016

NSCLC Trial in Worldwide (, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • placebo
  • BIBW 2992
  • Kingman, Arizona
  • +89 more
Jun 24, 2016

NSCLC Trial in New York (Pre-surgical Treatment with Bevacizumab plus Chemotherapy, Pre-Surgical Docetaxel and Cisplatin and

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Pre-surgical Treatment with Bevacizumab plus Chemotherapy
  • Pre-Surgical Docetaxel and Cisplatin and Adjuvant Bevacizumab
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 18, 2015

NSCLC Trial in Netherlands, United States (Cetuximab, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Aurora, Colorado
  • +5 more
Aug 29, 2015

NSCLC Trial in Worldwide (Cisplatin, Gemcitabine, PF-3512676)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +120 more
Mar 10, 2015

NSCLC Trial in Washington, Kansas City, New York (Tivozanib (AV-951))

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Tivozanib (AV-951)
  • Washington, District of Columbia
  • +2 more
Jun 27, 2012

Carcinoma, Non-small-cell Lung Trial in Worldwide (CP-675,206, best supportive care)

Completed
  • Carcinoma, Non-small-cell Lung
  • Bentonville, Arkansas
  • +25 more
Jun 5, 2012

NSCLC Trial in New York (Salirasib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 8, 2011

NSCLC Trial in United States (PF-3512676 + Erlotinib, Erlotinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Daphne, Alabama
  • +34 more
Dec 16, 2010

NSCLC, Head and Neck Tumors Trial in United States ([18F]-ML-10 in conjunction with PET imaging)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Head and Neck Neoplasms
  • [18F]-ML-10 in conjunction with PET imaging
  • Boston, Massachusetts
  • +3 more
Dec 16, 2010

NSCLC, Lung Tumors Trial in United States (MAC-321)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Los Angeles, California
  • +12 more
Aug 20, 2009

NSCLC Trial in United States (PD-0325901)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Greenbrae, California
  • +13 more
Mar 16, 2009